Human
papillomavirus (HPV) and Cytomegalovirus (CMV) therapeutics market
report studies current as well as future prospects of the market on a
global scale. The global market for HPV therapeutics is segmented by
drug class and applications. Various drug classes applied against HPV
infections are immunomodulators, keratolytic agents, anti-neoplastic
agents, and sinecatechins. The HPV therapeutics market is studied by
application segments which include genital warts, genital cancers,
epidermodysplasia verriformis, oral papillomas, and others
(oropharyngeal cancer, laryngeal papillomatosis and others). The
global HPV therapeutics market has been extensively analyzed on the
basis of the effectiveness and sales revenue of major drug classes as
well as geographic prevalence of various HPV infections.
Browse
Human Papillomavirus and Cytomegalovirus Therapeutics Market Report
with Full TOC at
http://www.transparencymarketresearch.com/hpv-cmv-therapeutics-market.html
The
global CMV therapeutics market is segmented by drugs and
applications. The major drugs prescribed for the treatment of CMV
infections are ganciclovir, valganciclovir, foscarnet, and cidofovir.
The CMV therapeutics treatment is applied against various CMV
infections causing retinitis, pneumonia, gastrointestinal ulcers,
encephalitis and others (mouth ulcers, pharyngitis and others).
Geographically,
the HPV and CMV therapeutics market has been categorized into five
regions namely, North America, Europe, South America, Asia Pacific,
and Rest of the World (ROW). The market size and forecast in terms of
USD million for each of these segments has been provided for the
period 2012 to 2020, considering 2012 and 2013 as base years. The HPV
and CMV therapeutics market report also provides compounded annual
growth rate (CAGR %) for each market segment for the forecast period
2014 to 2020.
The
report also provides pipeline analysis for HPV and CMV therapeutics
market, which includes sales forecast for drug candidates currently
under phase III clinical trials, and also mentions other candidates
in phase I and phase II trials. The research study explains the
competitive scenario in the HPV and CMV therapeutics market through
Porter’s Five Forces Analysis. A detailed analysis of various macro
as well as micro economic factors driving as well as restraining the
growth of this market, in addition to future opportunities, is
provided in the market overview section of the report. The report
also provides market attractiveness analysis and value chain analysis
of the global HPV and CMV therapeutics market. Market share analysis
for both HPV and CMV therapeutics market has been included.
Furthermore, pricing analysis of therapeutic drugs and costs
associated with treatment is also studied in the global HPV and CMV
therapeutics market report.
Request
for customization of this report
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3986
A
list of recommendations has been provided to help players establish a
strong presence in the market and increase their share. The report
also profiles major players in the HPV and CMV therapeutics market on
the basis of various attributes such as company overview, financial
overview, product portfolio, business strategies and recent
developments. Mergers, acquisitions, regulatory approvals and other
events have been explained in the company profiles section. Key
players profiled in the report include AbbVie, Inc., Actavis plc,
Clinigen Group plc, Merck & Co., Inc., Perrigo Company plc, Roche
Holdings AG and Valeant Pharmaceuticals International, Inc.
The
research methodology was based on primary as well as secondary
research. Interviews and discussions with a wide range of key
industry participants and opinion leaders revealed the real time
market scenario. This primary research represented the bulk of our
research efforts, which was further supplemented by extensive
secondary research. A bottom-up approach was adopted to arrive at
global market shares for 2012 and 2013; while an impact based
analysis model was adopted to forecast revenue for each market
segment. A review of key players’ product literature, annual
reports, and press releases supported the market forecast analysis.
The 117 pages global HPV and CMV therapeutics market report describes
various market dynamics in 51 figures and charts and 16 tables.
Browse
all Pharmaceutical Market Research Report
http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.htm
About
Us
Transparency
Market Research is a global market intelligence company, providing
global business information reports and services. Our exclusive blend
of quantitative forecasting and trends analysis provides
forward-looking insight for thousands of decision makers. We are
privileged with highly experienced team of Analysts, Researchers, and
Consultants, who use proprietary data sources and various tools and
techniques to gather, and analyze information.
Our
data repository is continuously updated and revised by a team of
research experts, so that it always reflects the latest trends and
information. With a broad research and analysis capability,
Transparency Market Research employs rigorous primary and secondary
research techniques in developing distinctive data sets and research
material for business reports.
Contact
Nachiket
State
Tower,
90
State Street,
Suite
700,
Albany
NY - 12207
United
States
USA
- Canada Toll Free: 866-552-3453
No comments:
Post a Comment